Imidazopyrazines for use as kinase inhibitors
There is provided compounds of formula (I), wherein R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g....
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | OYARZABAL SANTAMARINA JULEN PASTOR FERNANDEZ JOAQUIN MARTINEZ GONZALEZ SONIA |
description | There is provided compounds of formula (I), wherein R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN102428087BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN102428087BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN102428087BB3</originalsourceid><addsrcrecordid>eNrjZND1zM1MSazKL6gsSqzKzEstVkjLL1IoLU5VSCxWyM7MSwSyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbyzn6GBkYmRhYGFuZOTMVGKAEZDKww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Imidazopyrazines for use as kinase inhibitors</title><source>esp@cenet</source><creator>OYARZABAL SANTAMARINA JULEN ; PASTOR FERNANDEZ JOAQUIN ; MARTINEZ GONZALEZ SONIA</creator><creatorcontrib>OYARZABAL SANTAMARINA JULEN ; PASTOR FERNANDEZ JOAQUIN ; MARTINEZ GONZALEZ SONIA</creatorcontrib><description>There is provided compounds of formula (I), wherein R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150617&DB=EPODOC&CC=CN&NR=102428087B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150617&DB=EPODOC&CC=CN&NR=102428087B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OYARZABAL SANTAMARINA JULEN</creatorcontrib><creatorcontrib>PASTOR FERNANDEZ JOAQUIN</creatorcontrib><creatorcontrib>MARTINEZ GONZALEZ SONIA</creatorcontrib><title>Imidazopyrazines for use as kinase inhibitors</title><description>There is provided compounds of formula (I), wherein R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND1zM1MSazKL6gsSqzKzEstVkjLL1IoLU5VSCxWyM7MSwSyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbyzn6GBkYmRhYGFuZOTMVGKAEZDKww</recordid><startdate>20150617</startdate><enddate>20150617</enddate><creator>OYARZABAL SANTAMARINA JULEN</creator><creator>PASTOR FERNANDEZ JOAQUIN</creator><creator>MARTINEZ GONZALEZ SONIA</creator><scope>EVB</scope></search><sort><creationdate>20150617</creationdate><title>Imidazopyrazines for use as kinase inhibitors</title><author>OYARZABAL SANTAMARINA JULEN ; PASTOR FERNANDEZ JOAQUIN ; MARTINEZ GONZALEZ SONIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN102428087BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OYARZABAL SANTAMARINA JULEN</creatorcontrib><creatorcontrib>PASTOR FERNANDEZ JOAQUIN</creatorcontrib><creatorcontrib>MARTINEZ GONZALEZ SONIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OYARZABAL SANTAMARINA JULEN</au><au>PASTOR FERNANDEZ JOAQUIN</au><au>MARTINEZ GONZALEZ SONIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Imidazopyrazines for use as kinase inhibitors</title><date>2015-06-17</date><risdate>2015</risdate><abstract>There is provided compounds of formula (I), wherein R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_CN102428087BB |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Imidazopyrazines for use as kinase inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T21%3A28%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OYARZABAL%20SANTAMARINA%20JULEN&rft.date=2015-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN102428087BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |